Clinical trials
Cholangiocarcinoma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 6 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Terminated | 13 |
| Active, not recruiting | 11 |
| Recruiting | 10 |
| Unknown status | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 9 |
| AIO-Studien-gGmbH | 3 |
| AstraZeneca | 2 |
| Charite University, Berlin, Germany | 2 |
| Eli Lilly and Company | 2 |
| Incyte Corporation | 2 |
| Merck Sharp & Dohme LLC | 2 |
| PCI Biotech AS | 2 |
| QED Therapeutics, a BridgeBio company | 2 |
| Universitätsklinikum Hamburg-Eppendorf | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 59 |
| Gallbladder Neoplasms | 14 |
| Biliary Tract Neoplasms | 11 |
| Bile Duct Neoplasms | 10 |
| Pancreatic Neoplasms | 10 |
| Carcinoma, Hepatocellular | 9 |
| Liver Neoplasms | 8 |
| Stomach Neoplasms | 8 |
| Ovarian Neoplasms | 7 |
| Breast Neoplasms | 6 |
Trials
Showing 26 to 50 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.